Clinical Trial Update: UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for UM171 expanding cord blood in patients with high-risk acute leukemia or myelodysplastic syndromes. The study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• UM171

Snippet

Sponsor: Ciusss de L'Est de l'Île de Montréal | Conditions: High Risk Hematologic Malignancy, Cord Blood Transplant | Phase 2 | Status: ACTIVE_NOT_RECRUITING